Can Trulicity (Dulaglutide) Cause Heart Palpitations?
Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on July 15th, 2026.
Published on July 15th, 2026. Updated on July 15th, 2026.
Key takeaways
Dulaglutide raises resting heart rate by 2 to 3 beats per minute as a known class effect, which some patients perceive as palpitations or a racing sensation.
Palpitations are most likely to occur in the first 24 to 72 hours after each weekly injection and often improve as the body adjusts to the medication.
Indirect causes such as dehydration, nausea-related fluid loss, and hypoglycemia can trigger palpitations just as readily as the drug's direct effect on heart rate.
Warning signs like a sustained heart rate over 100 bpm at rest, irregular rhythm, chest pain, or fainting require prompt medical attention and should not be ignored.
Do not stop Trulicity without consulting a provider, as the drug carries meaningful cardiovascular benefits for many high-risk patients that outweigh nuisance symptoms.
What Dulaglutide Actually Does to Your Heart Rate
Trulicity (dulaglutide) belongs to a class of medications called GLP-1 receptor agonists, which work by mimicking the incretin hormone your gut naturally releases after eating. This action stimulates insulin secretion, slows digestion, and helps regulate blood sugar in people with type 2 diabetes. What many patients do not realize is that GLP-1 receptors are also present in cardiac tissue, meaning the drug can influence the heart directly.
Clinical trials consistently showed that dulaglutide increases resting heart rate by a mean of 2 to 3 beats per minute. That figure sounds small, but for some individuals, especially those who are sensitive to physical sensations, even a modest uptick in baseline heart rate can be felt as a fluttering, pounding, or racing sensation in the chest. This is not an accident or a rare anomaly. It is a recognized class effect that applies to all GLP-1 receptor agonists, not just Trulicity.
Palpitations as a Reported Side Effect
Heart palpitations are not listed as a common side effect in Trulicity's official prescribing information, but they have appeared in post-marketing surveillance reports, meaning patients have reported them after the drug reached the general market. This distinction matters because clinical trials often enroll carefully selected populations that may not capture every real-world experience.
The timing of palpitations tends to follow a predictable pattern. Symptoms most often appear within 24 to 72 hours of the weekly injection, which aligns with when dulaglutide reaches peak concentration in the bloodstream. For many patients, the sensations become less intense after the first few weeks as the body adapts. Starting at the lower 0.75 mg dose before escalating to 1.5 mg or higher gives the cardiovascular system more time to adjust, which may reduce symptom severity for patients who are particularly sensitive.
Indirect Causes That Can Make Palpitations Worse
Not every palpitation on Trulicity is caused by the drug's direct effect on heart rate. Several indirect mechanisms can amplify or even produce the sensation independently.
Nausea and vomiting are among the most common Trulicity side effects, and significant fluid loss from these symptoms can reduce blood volume. When blood volume drops, the heart compensates by beating faster, which patients may experience as palpitations. Staying well hydrated, particularly in the first days after each weekly injection, is a practical way to reduce this risk.
Hypoglycemia is another indirect trigger, especially in patients who take Trulicity alongside insulin or sulfonylureas. Low blood sugar triggers an adrenaline surge that causes the heart to race, producing a distinctive pounding sensation. Monitoring blood glucose closely and recognizing early hypoglycemia symptoms can help patients identify this as the cause rather than assuming the drug itself is responsible.
Finally, gastrointestinal discomfort and the anxiety it sometimes creates can heighten a person's awareness of their own heartbeat, making normal beats feel abnormal.
How Dulaglutide Compares to Similar Medications
All GLP-1 receptor agonists raise resting heart rate to some degree. The table below compares three commonly prescribed agents across key cardiovascular parameters.
Medication |
Mean Heart Rate Increase (bpm) |
Palpitations Reported in Trials |
Cardiovascular Outcome Trial Available |
|---|---|---|---|
Dulaglutide (Trulicity) |
2 to 3 |
Post-marketing reports |
Yes (REWIND trial) |
Semaglutide (Ozempic, Wegovy) |
3 to 4 |
Reported in trial data |
Yes (SUSTAIN-6, SOUL) |
Liraglutide (Victoza) |
2 to 3 |
Reported in trial data |
Yes (LEADER trial) |
Semaglutide tends to show a slightly higher mean heart rate increase than dulaglutide in head-to-head comparisons, while liraglutide carries a broadly similar cardiac profile to dulaglutide. Importantly, patients who experience intolerable palpitations on one agent do not always react the same way when switched to another. This is worth discussing with a provider if symptoms are significantly affecting quality of life.
Warning Signs That Need Prompt Attention
Most palpitations on Trulicity are benign and self-limiting, but certain features suggest a more serious problem that warrants prompt evaluation.
Seek medical attention if you experience any of the following alongside palpitations: a sustained heart rate over 100 beats per minute at rest, an irregular or chaotic heartbeat rhythm, chest pain or pressure, shortness of breath, dizziness, or fainting. These symptoms can signal arrhythmia or another cardiac event that is unrelated to Trulicity's typical mechanism and needs evaluation, possibly including an electrocardiogram.
Patients with pre-existing arrhythmias such as atrial fibrillation deserve particular attention. While FDA labeling does not broadly contraindicate Trulicity in cardiac patients, and the REWIND trial even demonstrated cardiovascular benefit in a high-risk population, individuals with complex arrhythmia histories should be monitored closely. The drug's effect on heart rate may interact unpredictably with certain rhythm disorders or with medications used to manage them.
Practical Steps for Managing Symptoms
If you notice palpitations after starting or dose-escalating Trulicity, a few straightforward strategies may help reduce their intensity without requiring you to stop the medication.
First, track your symptoms. Note when palpitations occur in relation to your injection day, how long they last, and whether any other symptoms accompany them. This information is valuable for any clinician you consult and can help distinguish drug-related symptoms from coincidental ones.
Second, prioritize hydration in the first two to three days after each injection. Dehydration compounds the heart rate increase dulaglutide already produces, so drinking adequate fluids can meaningfully reduce the perceived intensity of palpitations.
Third, if you are newly starting Trulicity, confirm with your provider that you are beginning on the lower 0.75 mg dose. Rushing to the higher dose before the body has adapted is one of the more avoidable reasons patients experience pronounced cardiovascular symptoms. Doctronic's 24/7 AI platform, which has supported more than 22 million consultations, can help you assess your symptoms and determine whether an in-person or video visit is the right next step.
Frequently Asked Questions
Yes, Trulicity can cause a mild increase in resting heart rate, typically 2 to 3 beats per minute, as a known effect of the GLP-1 receptor agonist drug class. Some patients perceive this increase as a racing or pounding sensation. The feeling tends to be most noticeable in the first few days after each weekly injection and often fades over time.
Palpitations linked to Trulicity often appear within 24 to 72 hours of the weekly injection and tend to ease as the body adapts to the medication. For many patients, symptoms become less noticeable after several weeks of consistent use. If palpitations persist or worsen beyond this window, a clinician evaluation is a reasonable next step.
Not without talking to your provider first. Mild, brief palpitations are often manageable without stopping the medication, and Trulicity carries important cardiovascular benefits for many patients. However, if palpitations come with chest pain, shortness of breath, or fainting, seek care immediately. A clinician can help you weigh the risks and benefits for your specific situation.
Trulicity primarily raises resting heart rate rather than disrupting rhythm. Arrhythmia is not a listed common side effect, but patients with pre-existing conditions like atrial fibrillation may be at higher risk for meaningful cardiac events and should be monitored closely by their care team while on this medication.
For many patients with established cardiovascular disease, Trulicity may actually be beneficial. The REWIND clinical trial demonstrated cardiovascular outcome benefits in a specific high-risk population. That said, patients with pre-existing arrhythmias or other complex cardiac histories should discuss the decision with a licensed clinician before starting or continuing dulaglutide.
The Bottom Line
Heart palpitations on Trulicity are real, plausible, and often manageable. Dulaglutide raises resting heart rate as a class effect, and indirect factors like dehydration or low blood sugar can amplify that sensation. For most patients, symptoms are mild and improve with time, good hydration, and gradual dose escalation. However, distinguishing a nuisance symptom from a genuine cardiac warning sign requires professional judgment. Doctronic offers 24/7 AI consultations with 99.2% treatment plan alignment with board-certified physicians, plus affordable $39 video visits, so you can get personalized guidance without delay. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.
Related articles
Get medical advice
Chat Now